A Trial of a Peptide-based Group A Streptococcal (GAS) Vaccine Candidate in Healthy Individuals.

NCT04882514 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Group A Streptococcal Infection

Interventions

BIOLOGICAL: p*17-K4S2
BIOLOGICAL: J8-K4S2
BIOLOGICAL: Rabavert vaccine

Sponsor

University of Alberta

Collaborators

[object Object]